Description

Rohypnol Flunitrazepam 1mg

Rohypnol (chemically known as flunitrazepam) is a highly potent, fast-acting oral benzodiazepine with profound sedative-hypnotic, muscle-relaxant, and anxiolytic properties. Originally developed in the 1970s by Roche Pharmaceuticals, it is clinically indicated in select countries for the short-term management of severe, debilitating insomnia and as a pre-surgical anesthetic.

Mechanism of Action

Rohypnol Flunitrazepam 1mg operates as a powerful central nervous system (CNS) depressant. Once ingested, it rapidly binds to specific benzodiazepine binding sites on the GABA-A receptors in the brain. This action enhances the inhibitory effects of gamma-aminobutyric acid (GABA), the brain’s primary calming neurotransmitter. The resulting influx of chloride ions hyperpolarizes the neurons, dramatically decreasing brain activity to induce deep sedation, muscle relaxation, and sleep.

 

Product Profile & Specifications

 

• Brand Name: Rohypnol.

• Active Substance: Flunitrazepam.

• Formulation: Oral tablets. Modern legitimate manufacturing utilizes specialized tablets containing a slow-release blue dye to make the substance highly visible if dissolved in liquids.

• Chemical Class: Benzodiazepine.

• Onset of Action: Very rapid, taking effect shortly after oral ingestion.

• Duration & Half-Life: Features an intermediate elimination half-life, meaning its sedating effects can persist heavily into the following day.

 

Clinical Effects & Indications

When utilized under strict, short-term medical supervision, the drug delivers definitive therapeutic actions:

• Deep Sedation: Rapidly induces sleep in patients suffering from severe, chronic insomnia that has failed to respond to other treatments.

• Anterograde Amnesia: Causes a temporary inability to form new memories while under the influence of the drug, which is clinically useful as a pre-medication before surgical procedures.